These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3934784)

  • 1. Aspirin, indomethacin and dazoxiben do not affect the fibrinolytic activation induced by venous occlusion.
    Bounameaux H; Gresele P; Hanss M; De Cock F; Vermylen J; Collen D
    Thromb Res; 1985 Oct; 40(2):161-70. PubMed ID: 3934784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin is required for t-PA release after venous occlusion.
    Iacoviello L; De Curtis A; D'Adamo MC; Amore C; Buczko W; De Gaetano G; Donati MB
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H429-34. PubMed ID: 7511345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids.
    Iacoviello L; Amore C; De Curtis A; Tacconi MT; de Gaetano G; Cerletti C; Donati MB
    Arterioscler Thromb; 1992 Oct; 12(10):1191-7. PubMed ID: 1390591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
    Gresele P; Arnout J; Deckmyn H; Huybrechts E; Pieters G; Vermylen J
    J Clin Invest; 1987 Nov; 80(5):1435-45. PubMed ID: 2960694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin decreases fibrinolytic potential during venous occlusion, but not during acute physical activity.
    Keber I; Jereb M; Keber D
    Thromb Res; 1987 Apr; 46(2):205-12. PubMed ID: 3111000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and venous occlusion: effects on blood fibrinolytic activity and tissue-type plasminogen activator levels.
    Hammouda MW; Moroz LA
    Thromb Res; 1986 Apr; 42(1):73-82. PubMed ID: 3085277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of aspirin on fibrinolysis is reversed by iloprost, a prostacyclin analogue.
    Bertelé V; Mussoni L; Pintucci G; del Rosso G; Romano G; de Gaetano G; Libretti A
    Thromb Haemost; 1989 Apr; 61(2):286-8. PubMed ID: 2473539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aspirin on the fibrinolytic response in perfused rat hindquarters.
    Iacoviello L; De Curtis A; Amore C; D'Adamo MC; Buczko W; de Gaetano G; Donati MB
    Eur J Pharmacol; 1992 Dec; 229(1):39-44. PubMed ID: 1473562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of retinoids on fibrinolysis before and after venous occlusion in healthy humans.
    Bounameaux H; Reber G; Bounameaux Y
    Thromb Res; 1988 Apr; 50(1):175-9. PubMed ID: 3400079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dazoxiben, an inhibitor of thromboxane synthetase, on forearm vasoconstriction in response to cold stimulation, and on human blood vessel prostacyclin production.
    Cowley AJ; Jones EW; Hanley SP
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):107S-112S. PubMed ID: 6337600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
    Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
    Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M; Mavri A
    Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
    Menys VC; Davies JA
    Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of plasminogen activator inhibitor activity by plasmin in endothelial cells.
    Shi GY; Wang SJ; Chang B; Tasi CF; Lin MT; Chang WC; Wing LY; Jen CJ; Wu HL
    Thromb Res; 1996 Jan; 81(1):75-84. PubMed ID: 8747522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.